Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC
Status:
Terminated
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The overall goal of this study is to determine the safety and efficacy of combination
treatment of low-dose fractionated radiation therapy with gemcitabine-cisplatin chemotherapy
for locally advanced mass forming intra-hepatic cholangiocarcinoma.